The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zaytseva O.V.

Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry

Neroeva N.V.

Helmholtz National Medical Research Center of Eye Diseases

Okhotsimskaya T.D.

Helmholtz National Medical Research Center of Eye Diseases

Bobykin E.V.

Ural State Medical University

Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response

Authors:

Zaytseva O.V., Neroeva N.V., Okhotsimskaya T.D., Bobykin E.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(5): 152‑159

Views: 2307

Downloaded: 123


To cite this article:

Zaytseva OV, Neroeva NV, Okhotsimskaya TD, Bobykin EV. Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response. Russian Annals of Ophthalmology. 2021;137(5):152‑159. (In Russ.)
https://doi.org/10.17116/oftalma2021137051152

Recommended articles:
Glucocorticoid-resistant forms of endo­crine ophthalmopathy. Russian Annals of Ophthalmology. 2024;(6):125-130
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Choroidal neovascularization asso­ciated with choroidal nevi. Russian Annals of Ophthalmology. 2025;(1):104-112

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.